Abstract
Chronic neuroinflammation (activation of microglia and astrocytes) is a prominent pathological process in many neurodegenerative diseases including Alzheimer's disease (AD). Consequently, it has been suggested that drugs targeting neuroinflammatory processes such as cytokine-suppressive anti-inflammatory drugs (CSAIDs) such as apigenin (major bioactive compound in parsley) might yield clinically useful disease- modifying effect for these neurodegenerative disorders. The present study aimed to investigate the therapeutic effect of apigenin on neuroinflammation in the glial fibrillary acidic protein-interleukin 6 (GFAPIL6) expressing mouse using both immunohistochemical and behavioral tests.
| Original language | English |
|---|---|
| Title of host publication | Free Radical Biology and Medicine. Volume 108, Supplement 1: Abstracts of the OCC World Congress and Annual SFRR-E Conference 2017: Metabolic Stress and Redox Regulation, Berlin, Germany, 21-23 June 2017 |
| Publisher | Elsevier |
| Pages | S10-S10 |
| Number of pages | 1 |
| DOIs | |
| Publication status | Published - 2017 |
| Event | Oxygen Club of California. World Congress - Duration: 1 Jan 2017 → … |
Conference
| Conference | Oxygen Club of California. World Congress |
|---|---|
| Period | 1/01/17 → … |
Keywords
- apigenin
- anti-inflammatory agents
- Alzheimer's disease
- cytokines
- parsley